Lakefront Biotherapeutics | GLPG - Kısa Vadeli Yükümlülükler





Kısa Vadeli Yükümlülükler Değişiklik Tarih
argenx SE USD 1.58B 254.81M 2026-06
AstraZeneca USD 31.27B 286M 2026-09
Biogen USD 3.9B 18.7M 2026-09
Genmab DKK 1.14B 38M 2026-06
Gilead Sciences USD 12B 982M 2026-09
GlaxoSmithKline GBP 20.72B 814M 2026-09
GRIFOLS EUR 2.3B 59M 2026-09
Hikma Pharmaceutical USD 1.45B 603M 2025-12
Incyte USD 1.44B 125.72M 2026-09
Merck EUR 8.12B 1.22B 2026-06
Neurocrine Biosciences USD 984.6M 110.1M 2026-09
Novartis USD 32.52B 777M 2026-09
Roche Holding CHF 28.85B 846M 2026-06
Sanofi EUR 29.77B 2.16B 2026-09
UCB EUR 4.4B 470M 2025-12
Vertex Pharmaceuticals USD 5B 1.06B 2026-09